DBV Technologies (DBVT) Revenue (2020 - 2026)

DBV Technologies (DBVT) reported Revenue of $900000.0 for Q1 2026, up 12.5% year-over-year from $800000.0 in Q1 2025, and up 39.53% quarter-over-quarter from $645000.0 in Q4 2025.

DBV Technologies (DBVT) Revenue (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 7 years of Revenue data on file, last reported at $900000.0 in Q1 2026.

  • Revenue for Q1 2026 came in at $900000.0, up 12.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (up 63.21% YoY), and the FY2025 annual result was $5.6 million, up 35.77% from the prior year.
  • Revenue rose to $900000.0 in Q1 2026 per DBVT's latest filing, from $645000.0 in the prior quarter.
  • Over five years, Revenue peaked at $8.9 million in Q4 2023 and troughed at -$1.3 million in Q4 2022.
  • A 5-year average of $1.8 million and a median of $1.5 million in 2025 frame the typical range for Revenue.
  • The sharpest annual moves came in 2022 and 2023: Revenue sank 144.47% in 2022, then surged 780.6% in 2023.
  • A 5-year view of Revenue shows it stood at -$1.3 million in 2022, then surged by 780.6% to $8.9 million in 2023, then tumbled by 94.24% to $511000.0 in 2024, then gained by 26.22% to $645000.0 in 2025, then soared by 39.53% to $900000.0 in 2026.
  • Business Quant data shows DBVT's Revenue at $900000.0 in Q1 2026, $645000.0 in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 900,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Dec 31, 2025 645,000.00
Sep 30, 2025 2.77 Mn
Jun 30, 2025 1.47 Mn
Mar 31, 2025 800,000.00
Dec 31, 2024 511,000.00
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 1.41 Mn
Dec 31, 2023 8.88 Mn
Sep 30, 2023 2.37 Mn
Jun 30, 2023 2.29 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 2.07 Mn
Jun 30, 2022 1.53 Mn
Mar 31, 2022 2.55 Mn
Dec 31, 2021 2.93 Mn
Sep 30, 2021 1.32 Mn
Jun 30, 2021 1.49 Mn